Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 11/2007

Open Access 01-11-2007 | Editorial

The international classification for functioning, disability and health

A challenge and a need for rheumatology

Authors: Annelies Boonen, Johannes J. Rasker, Gerold Stucki

Published in: Clinical Rheumatology | Issue 11/2007

Login to get access

Excerpt

Health information is the glue that holds a health system together. In most countries stronger, more integrated information systems are required [1].
…
Literature
1.
WHO (2005) WHO business plan for classifications. Building blocks of health information, report no.: V 1.0. World Health Organization, Geneva
2.
Cornelissen PG, Rasker JJ, Valkenburg HA (1988) The arthritis sufferer and the community: a comparison of arthritis sufferers in rural and urban areas. Ann Rheum Dis 47:150–156PubMedCrossRef
3.
WHO (2001) The International Classification of Functioning, Disability and Health. World Health Organization, Geneva
4.
WHO (1992) International statistical classification of diseases and related health problems. World Health Association, Geneva
5.
Steinbrocker O (1969) Prognosis for employability in the major arthritides rheumatoid arthritis, osteoarthritis and gout. Pa Med 72:82–85PubMed
6.
Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145PubMedCrossRef
7.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed
8.
Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38:878–882PubMedCrossRef
9.
Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733PubMed
10.
Lequesne M (1991) Indices of severity and disease activity for osteoarthritis. Semin Arthritis Rheum 20(6 Suppl 2):48–54PubMedCrossRef
11.
Hunt SM, McKenna SP, McEwen J, Williams J, Papp E (1981) The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 15(3 Pt 1):221–229
12.
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef
13.
Backman C, Mackie H, Harris J (1991) Arthritis hand function test: development of a standardised assessment tool. Occup Ther J Res 11:246–256
14.
Dellhag B, Bjelle A (1995) A grip ability test for use in rheumatology practice. J Rheumatol 22:1559–1565PubMed
15.
Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, Revel M (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23:1167–1172PubMed
16.
Nagi S (1991) Disability concepts revisited: implications for prevention. In: Pope A, Tarlov V (eds) Disability in America: towards a national agenda for prevention. National Academy Press, Washington, DC
17.
WHO (1980) International Classification of Impairments, Disabilities and Handicaps: a manual for classification relating to the consequence of disease. Geneva
18.
WHO (1947) Constitution of the World Health Organization. World Health Organization, Geneva
19.
Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Ustun TB (2002) Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil 24:281–282PubMedCrossRef
20.
Cieza A, Schwarzkopf S, Sigl T, Stucki G, Melvin J, Stoll T, Woolf A, Kostanjsek N, Walsh N (2004) ICF Core Sets for osteoporosis. J Rehabil Med 44 Suppl:81–86PubMedCrossRef
21.
Cieza A, Stucki G, Weigl M, Disler P, Jackel W, van der Linden S, Kostanjsek N, de Bie R (2004) ICF Core Sets for low back pain. J Rehabil Med 44 Suppl:69–74PubMedCrossRef
22.
Cieza A, Stucki G, Weigl M, Kullmann L, Stoll T, Kamen L, Kostanjsek N, Walsh N (2004) ICF Core Sets for chronic widespread pain. J Rehabil Med 44 Suppl:63–68PubMedCrossRef
23.
Dreinhofer K, Stucki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A (2004) ICF Core Sets for osteoarthritis. J Rehabil Med 44 Suppl:75–80PubMed
24.
Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, Kostanjsek N, Schouten J (2004) ICF Core Sets for rheumatoid arthritis. J Rehabil Med 44 Suppl:87–93PubMedCrossRef
25.
Sigl T, Cieza A, van der Heijde D, Stucki G (2005) ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis. Ann Rheum Dis 64:1576–1581PubMedCrossRef
26.
van Echteld I, Cieza A, Boonen A, Stucki G, Zochling J, Braun J, van der Heijde D (2006) Identification of the most common problems by patients with ankylosing spondylitis using the International Classification of Functioning, Disability and Health. J Rheumatol 33:2475–2483PubMed
27.
Stucki G, Ustun TB, Melvin J (2005) Applying the ICF for the acute hospital and early post-acute rehabilitation facilities. Disabil Rehabil 27:349–352PubMedCrossRef
28.
Zochling J, Grill E, Scheuringer M, Liman W, Stucki G, Braun J (2006) Identification of health problems in patients with acute inflammatory arthritis, using the International Classification of Functioning, Disability and Health (ICF). Clin Exp Rheumatol 24:239–246PubMed
29.
Stoll T, Brach M, Huber EO, Scheuringer M, Schwarzkopf SR, Konstanjsek N, Stucki G (2005) ICF Core Set for patients with musculoskeletal conditions in the acute hospital. Disabil Rehabil 27:381–387PubMedCrossRef
30.
Cieza A, Ewert T, Ustun TB, Chatterji S, Kostanjsek N, Stucki G (2004) Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med 44 Suppl:9–11PubMed
31.
International Classification of Functioning, Disability and Health (2001) World Health Organization, Geneva
32.
Heerkens Y, Engels J, Kuiper C, Van der Gulden J, Oostendorp R (2004) The use of the ICF to describe work related factors influencing the health of employees. Disabil Rehabil 26:1060–1066PubMedCrossRef
33.
Heerkens Y, van der Brug Y, Napel HT, van Ravensberg D (2003) Past and future use of the ICF (former ICIDH) by nursing and allied health professionals. Disabil Rehabil 25:620–627PubMedCrossRef
34.
Taal E, Bobietinska E, Lloyd J, Veehof M, Rasker WJ, Oosterveld FG, Rasker JJ (2006) Successfully living with chronic arthritis. The role of the allied health professionals. Clin Rheumatol 25:189–197PubMedCrossRef
35.
Uhlig T, Lillemo S, Moe RH, Stamm T, Cieza A, Boonen A, Mowinckel P, Kvien TK, Stucki GD (2007) Reliability of the ICF core set for rheumatoid arthritis. Ann Rheum Dis
36.
Verstappen SM, Bijlsma JW, Verkleij H, Buskens E, Blaauw AA, ter Borg EJ, Jacobs JW (2004) Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum 51:488–497PubMedCrossRef
37.
Boonen A, de Vet H, van der Heijde D, van der Linden S (2001) Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol 28:1056–1062PubMed
38.
Boonen A (2005) Everyone has the right to work. J Rheumatol 32(4):571–574PubMed
39.
Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, Strand CV, Beaton DE (2007). Worker productivity outcome measures in arthritis. J Rheumatol 34:1372–1380
40.
Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE (1992) AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 35:1–10PubMedCrossRef
Metadata
Title
The international classification for functioning, disability and health
A challenge and a need for rheumatology
Authors
Annelies Boonen
Johannes J. Rasker
Gerold Stucki
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 11/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0623-0

Other articles of this Issue 11/2007

Clinical Rheumatology 11/2007 Go to the issue

Case Report

Acute pseudoseptic arthritis after viscosupplementation of the knee: a case report

Brief Report

Can breastfeeding avert the appearance of growth pains during childhood?

Case Report

Ankylosing spondylitis presenting with macrophage activation syndrome

Original Article

Osteoarthritis of the knee and hip: a comparison of factors associated with physical activity

Original Article

Quantitative salivary gland scintigraphy can distinguish patients with primary Sjøgren’s syndrome during the evaluation of sicca symptoms

Case Report

Limited Wegener’s granulomatosis—is it limited?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits